tiprankstipranks
Trending News
More News >
Amphastar Pharmaceuticals (AMPH)
NASDAQ:AMPH
US Market

Amphastar Pharmaceuticals (AMPH) Ratios

Compare
400 Followers

Amphastar Pharmaceuticals Ratios

AMPH's free cash flow for Q1 2025 was $0.50. For the 2025 fiscal year, AMPH's free cash flow was decreased by $ and operating cash flow was $0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.99 2.17 3.99 3.06 2.49
Quick Ratio
2.90 1.70 2.90 2.17 1.63
Cash Ratio
1.65 0.64 1.65 1.22 0.83
Solvency Ratio
0.56 0.21 0.56 0.39 0.14
Operating Cash Flow Ratio
0.94 0.81 0.94 0.94 0.51
Short-Term Operating Cash Flow Coverage
14.74 420.88 14.74 18.90 3.67
Net Current Asset Value
$ 164.99M$ -383.89M$ 164.99M$ 92.11M$ 97.17M
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.41 0.14 0.16 0.11
Debt-to-Equity Ratio
0.19 0.98 0.19 0.23 0.17
Debt-to-Capital Ratio
0.16 0.49 0.16 0.19 0.14
Long-Term Debt-to-Capital Ratio
0.12 0.48 0.12 0.14 0.08
Financial Leverage Ratio
1.40 2.37 1.40 1.51 1.57
Debt Service Coverage Ratio
10.64 7.55 10.64 15.02 1.67
Interest Coverage Ratio
42.66 7.25 42.66 48.74 -38.04
Debt to Market Cap
0.06 0.20 0.06 0.07 0.05
Interest Debt Per Share
2.15 13.48 2.15 2.21 1.44
Net Debt to EBITDA
-0.50 1.99 -0.50 -0.19 -0.84
Profitability Margins
Gross Profit Margin
49.87%54.49%49.87%45.63%40.97%
EBIT Margin
21.54%30.81%21.54%19.42%1.43%
EBITDA Margin
21.54%37.29%21.54%25.53%8.63%
Operating Profit Margin
15.78%30.57%15.78%9.85%-4.07%
Pretax Profit Margin
23.26%26.59%23.26%19.22%1.33%
Net Profit Margin
18.31%21.34%18.31%14.19%0.31%
Continuous Operations Profit Margin
18.31%21.34%18.31%14.46%0.31%
Net Income Per EBT
78.75%80.27%78.75%73.83%23.66%
EBT Per EBIT
147.34%86.99%147.34%195.06%-32.60%
Return on Assets (ROA)
12.32%9.09%12.32%9.25%0.17%
Return on Equity (ROE)
17.29%21.51%17.29%13.94%0.27%
Return on Capital Employed (ROCE)
12.17%15.30%12.17%7.60%-2.74%
Return on Invested Capital (ROIC)
9.57%12.42%9.57%5.65%-0.63%
Return on Tangible Assets
12.97%15.29%12.97%9.82%0.19%
Earnings Yield
6.72%4.61%6.72%5.58%0.12%
Efficiency Ratios
Receivables Turnover
5.62 5.61 5.62 5.56 5.30
Payables Turnover
12.20 11.53 12.20 10.72 8.48
Inventory Turnover
2.41 2.77 2.41 2.56 2.13
Fixed Asset Turnover
1.89 2.04 1.89 1.61 1.25
Asset Turnover
0.67 0.43 0.67 0.65 0.55
Working Capital Turnover Ratio
2.00 2.35 2.00 2.29 2.10
Cash Conversion Cycle
186.20 165.16 186.20 173.95 196.96
Days of Sales Outstanding
64.96 65.11 64.96 65.70 68.86
Days of Inventory Outstanding
151.16 131.72 151.16 142.31 171.15
Days of Payables Outstanding
29.92 31.66 29.92 34.06 43.05
Operating Cycle
216.11 196.82 216.11 208.02 240.01
Cash Flow Ratios
Operating Cash Flow Per Share
1.84 3.80 1.84 2.05 1.22
Free Cash Flow Per Share
1.34 3.01 1.34 1.48 0.50
CapEx Per Share
0.50 0.79 0.50 0.57 0.72
Free Cash Flow to Operating Cash Flow
0.73 0.79 0.73 0.72 0.41
Dividend Paid and CapEx Coverage Ratio
3.71 4.81 3.71 3.57 1.69
Capital Expenditure Coverage Ratio
3.71 4.81 3.71 3.57 1.69
Operating Cash Flow Coverage Ratio
0.87 0.29 0.87 0.94 0.85
Operating Cash Flow to Sales Ratio
0.18 0.28 0.18 0.22 0.16
Free Cash Flow Yield
4.79%4.87%4.79%6.34%2.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
14.89 21.70 14.89 17.91 862.29
Price-to-Sales (P/S) Ratio
2.73 4.63 2.73 2.54 2.70
Price-to-Book (P/B) Ratio
2.57 4.67 2.57 2.50 2.35
Price-to-Free Cash Flow (P/FCF) Ratio
20.88 20.54 20.88 15.77 40.41
Price-to-Operating Cash Flow Ratio
15.25 16.27 15.25 11.36 16.52
Price-to-Earnings Growth (PEG) Ratio
0.33 0.42 0.33 <0.01 -8.82
Price-to-Fair Value
2.57 4.67 2.57 2.50 2.35
Enterprise Value Multiple
12.16 14.42 12.16 9.76 30.49
Enterprise Value
1.31B 3.46B 1.31B 1.09B 920.56M
EV to EBITDA
12.16 14.42 12.16 9.76 30.49
EV to Sales
2.62 5.38 2.62 2.49 2.63
EV to Free Cash Flow
20.06 23.84 20.06 15.47 39.32
EV to Operating Cash Flow
14.65 18.88 14.65 11.13 16.08
Tangible Book Value Per Share
10.12 0.54 10.12 8.51 8.68
Shareholders’ Equity Per Share
10.89 13.25 10.89 9.33 8.55
Tax and Other Ratios
Effective Tax Rate
0.20 0.19 0.20 0.25 0.76
Revenue Per Share
10.28 13.35 10.28 9.16 7.44
Net Income Per Share
1.88 2.85 1.88 1.30 0.02
Tax Burden
0.79 0.80 0.79 0.74 0.24
Interest Burden
1.08 0.86 1.08 0.99 0.93
Research & Development to Revenue
0.15 0.11 0.15 0.14 0.19
SG&A to Revenue
0.09 0.08 0.09 0.12 0.14
Stock-Based Compensation to Revenue
0.04 0.03 0.04 0.04 0.06
Income Quality
0.98 1.33 0.98 1.55 52.20
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis